Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Capricor Therapeutics | CAPR | 16. oct 2024 | 20.51 | -5.05 |
Captivision | CAPT | 16. oct 2024 | 1.72 | -3.91 |
Cara Therapeutics | CARA | 16. oct 2024 | 0.27 | +3.92 |
Caravelle International Group | CACO | 16. oct 2024 | 0.44 | 0.00 |
Carbon Revolution | CREV | 16. oct 2024 | 3.67 | +0.63 |
Cardiff Oncology | CRDF | 16. oct 2024 | 2.79 | +4.49 |
Cardinal Health | CAH | 16. oct 2024 | 112.55 | +0.51 |
Cardio Diagnostics | CDIO | 16. oct 2024 | 0.23 | +6.63 |
Cardiol Therapeutics | CRDL | 16. oct 2024 | 1.90 | -0.52 |
Cardlytics | CDLX | 16. oct 2024 | 3.84 | +1.72 |
CareCloud | CCLD | 16. oct 2024 | 2.59 | +3.60 |
CareCloud A Pref | CCLDP | 16. oct 2024 | 11.24 | +0.36 |
CareCloud B Pref | CCLDO | 16. oct 2024 | 11.86 | +0.78 |
CareDx | CDNA | 16. oct 2024 | 26.18 | -0.65 |
CareMax A | CMAX | 16. oct 2024 | 1.93 | -1.53 |
CareTrust REIT | CTRE | 16. oct 2024 | 31.01 | +1.31 |
CARGO Therapeutics | CRGX | 16. oct 2024 | 23.03 | +5.40 |
CarGurus A | CARG | 16. oct 2024 | 31.64 | +0.60 |
Caribou Biosciences | CRBU | 16. oct 2024 | 2.06 | +5.64 |
Carisma Therapeutics | CARM | 16. oct 2024 | 0.97 | +2.20 |
Carlisle Companies | CSL | 16. oct 2024 | 462.43 | -1.93 |
Carlyle Credit Income Fund | CCIA | 16. oct 2024 | 26.01 | -0.15 |
Carlyle Credit Income Fund | CCIF | 16. oct 2024 | 8.38 | -0.18 |
Carlyle Secured Lending | CGBD | 16. oct 2024 | 17.82 | +2.41 |
CarMax | KMX | 16. oct 2024 | 74.81 | +1.55 |
Carmell | CTCX | 16. oct 2024 | 0.63 | +82.04 |
Carnival | CCL | 16. oct 2024 | 21.40 | -0.70 |
Carnival ADR | CUK | 16. oct 2024 | 19.56 | -0.66 |
CarParts.com | PRTS | 16. oct 2024 | 0.81 | +1.88 |
Carpenter Technology | CRS | 16. oct 2024 | 159.71 | +2.26 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.